Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 CAD | 0.00% |
|
0.00% | +9.52% |
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jacek Antas
CEO | Chief Executive Officer | - | 17/04/22 |
Director of Finance/CFO | 59 | 02-13 | |
Chief Tech/Sci/R&D Officer | - | 31/08/22 | |
Chief Tech/Sci/R&D Officer | - | 30/11/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 17/04/22 | |
Jacek Antas
CEO | Chief Executive Officer | - | 17/04/22 |
Malgorzata Laube
BRD | Director/Board Member | - | 07/12/22 |
Janusz Grabski
BRD | Director/Board Member | - | 21/08/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 245,107,749 | 198,187,874 ( 80.86 %) | 0 | 80.86 % |
Company contact information
![address Helix BioPharma Corp.(HBP)](https://cdn.zonebourse.com/static/address/1410302.png)
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.52% | 41.28M | |
+38.36% | 52.73B | |
+36.73% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- HBP Stock
- Company Helix BioPharma Corp.